261 related articles for article (PubMed ID: 34314921)
1. Diabetes mellitus and Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): A wake-up call from Egypt.
Alfishawy M; Elbendary A; Younes A; Negm A; Hassan WS; Osman SH; Nassar M; Elanany MG
Diabetes Metab Syndr; 2021; 15(5):102195. PubMed ID: 34314921
[No Abstract] [Full Text] [Related]
2. Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.
Pakdel F; Ahmadikia K; Salehi M; Tabari A; Jafari R; Mehrparvar G; Rezaie Y; Rajaeih S; Alijani N; Barac A; Abdollahi A; Khodavaisy S
Mycoses; 2021 Oct; 64(10):1238-1252. PubMed ID: 34096653
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 associated mucormycosis: A Descriptive Multisite Study from India.
Gupta R; Kesavadev J; Krishnan G; Agarwal S; Saboo B; Shah M; Mittal A; Durani S; Luthra A; Singhal A; Rasheed M; Rao GVS; Tripathi V; Jha A; Ghosh A; Mohan V; Singh AK; Phatak S; Panicker J; Bhadada SK; Joshi S; Pal R; Mithal A; Vikram N; Misra A
Diabetes Metab Syndr; 2021; 15(6):102322. PubMed ID: 34717135
[TBL] [Abstract][Full Text] [Related]
4. Re: 'Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis' by Manesh et al.
Muthu V; Agarwal R; Chakrabarti A
Clin Microbiol Infect; 2023 Nov; 29(11):1461-1462. PubMed ID: 37473841
[No Abstract] [Full Text] [Related]
5. Palatal mucormycosis in a patient with SARS-CoV-2 infection.
Venugopal A; Marya A
CMAJ; 2021 Aug; 193(32):E1254. PubMed ID: 34400485
[No Abstract] [Full Text] [Related]
6. COVID-19 associated mucormycosis - An emerging threat.
Chao CM; Lai CC; Yu WL
J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of pulmonary mucormycosis, a rare pulmonary fungal infection, in a patient with diabetes mellitus.
Zaizen Y; Ohtsu T
J Thorac Cardiovasc Surg; 2002 Oct; 124(4):838-40. PubMed ID: 12324746
[No Abstract] [Full Text] [Related]
8. Case Report: Rhino-orbital Mucormycosis Related to COVID-19: A Case Series Exploring Risk Factors.
Aggarwal SK; Kaur U; Talda D; Pandey A; Jaiswal S; Kanakan A; Singh A; Chakrabarti SS
Am J Trop Med Hyg; 2021 Dec; 106(2):566-570. PubMed ID: 34902834
[TBL] [Abstract][Full Text] [Related]
9. Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: author's response.
Mukaka M; Manesh A; Varghese GM
Clin Microbiol Infect; 2023 Nov; 29(11):1463-1464. PubMed ID: 37516382
[No Abstract] [Full Text] [Related]
10. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India.
Mishra Y; Prashar M; Sharma D; Akash ; Kumar VP; Tilak TVSVGK
Diabetes Metab Syndr; 2021; 15(4):102196. PubMed ID: 34246939
[TBL] [Abstract][Full Text] [Related]
11. Management of bronchovascular mucormycosis in a diabetic: a surgical success.
Reid VJ; Solnik DL; Daskalakis T; Sheka KP
Ann Thorac Surg; 2004 Oct; 78(4):1449-51. PubMed ID: 15464515
[TBL] [Abstract][Full Text] [Related]
12. [Fatal pulmonary mucormycosis in a diabetic patient].
Vichova Z; Beuret P; Boyer M; Chanoz J
Ann Fr Anesth Reanim; 2006 Jan; 25(1):40-2. PubMed ID: 16226426
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India.
Aranjani JM; Manuel A; Abdul Razack HI; Mathew ST
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009921. PubMed ID: 34793455
[TBL] [Abstract][Full Text] [Related]
14. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.
Rudramurthy SM; Hoenigl M; Meis JF; Cornely OA; Muthu V; Gangneux JP; Perfect J; Chakrabarti A;
Mycoses; 2021 Sep; 64(9):1028-1037. PubMed ID: 34133816
[TBL] [Abstract][Full Text] [Related]
15. Mucormycosis and COVID-19: An epidemic within a pandemic in India.
Selarka L; Sharma S; Saini D; Sharma S; Batra A; Waghmare VT; Dileep P; Patel S; Shah M; Parikh T; Darji P; Patel A; Goswami G; Shah A; Shah S; Lathiya H; Shah M; Sharma P; Chopra S; Gupta A; Jain N; Khan E; Sharma VK; Sharma AK; Chan ACY; Ong JJY
Mycoses; 2021 Oct; 64(10):1253-1260. PubMed ID: 34255907
[TBL] [Abstract][Full Text] [Related]
16. The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis.
Ahmadikia K; Hashemi SJ; Khodavaisy S; Getso MI; Alijani N; Badali H; Mirhendi H; Salehi M; Tabari A; Mohammadi Ardehali M; Kord M; Roilides E; Rezaie S
Mycoses; 2021 Aug; 64(8):798-808. PubMed ID: 33590551
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?
Revannavar SM; P S S; Samaga L; V K V
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33906877
[TBL] [Abstract][Full Text] [Related]
19. Desensitization to liposomal amphotericin B after anaphylaxis in a patient with COVID-19-associated mucormycosis - A case with review of literature.
Swain S; Ray A; Wig N; Trikha A
Indian J Pharmacol; 2022; 54(2):150-152. PubMed ID: 35546469
[No Abstract] [Full Text] [Related]
20. Clinical Analysis of Diabetic Combined Pulmonary Mucormycosis.
Li YH; Sun P; Guo JC
Mycopathologia; 2017 Dec; 182(11-12):1111-1117. PubMed ID: 28667347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
